← All trials
NCT01783041
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 1, 2013
- Primary completion
- Dec 1, 2016
- Completion date
- Aug 1, 2020
- First posted
- —
- Last posted
- —
- Enrollment
- 150
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- Yeshiva UniversityLead sponsor
- Yeshiva UniversityOverall official - principal investigator
- The Gerber FoundationCollaborator
- Yeshiva UniversityReponsible party - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.